Surfing the MASH Tsunami
Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL
Surfing the MASH Tsunami
How Have The Events of 2020 Affected Patient Treatment In The Clinic? Ep 31
Guest Surfer and regular listener Dr. Ian Rowe joins the Surfers to discuss how everyday patient treatment in the clinic once was and how COVID-19 and the news we discuss weekly on SurfingNASH have changed practice.
This week's Guest Surfer, Dr. Ian Rowe, devotes roughly half his time to treating patients in his Hepatology practice in Leeds, UK, and the other half on research and teaching issues. He joined the Surfers to discuss how patients were referred to his clinic and how he treated them before COVID-19, and how the demands of the pandemic have changed practices in the clinic. Not surprisingly, the conversation turned to the best way to use the diagnostics we have and how events of the past year have increased the productive focus on using better diagnostics while simultaneously using diagnostics better. Along the way, learn about a significant research effort (350,000 patient records!) Dr. Rowe and his colleague, Dr. Richard Parker have undertaken and why sequential use of multiple non-invasive tests may offer the winning strategy for improving patient treatment.